BRPI0706921A8 - Material para enxerto ósseo, arcabouço para aplicações de engenharia de tecido, composição farmacêutica para a recuperação da regeneração de tecidos - Google Patents

Material para enxerto ósseo, arcabouço para aplicações de engenharia de tecido, composição farmacêutica para a recuperação da regeneração de tecidos

Info

Publication number
BRPI0706921A8
BRPI0706921A8 BRPI0706921A BRPI0706921A BRPI0706921A8 BR PI0706921 A8 BRPI0706921 A8 BR PI0706921A8 BR PI0706921 A BRPI0706921 A BR PI0706921A BR PI0706921 A BRPI0706921 A BR PI0706921A BR PI0706921 A8 BRPI0706921 A8 BR PI0706921A8
Authority
BR
Brazil
Prior art keywords
tissue
pharmaceutical composition
tissue engineering
engineering applications
scaffold
Prior art date
Application number
BRPI0706921A
Other languages
English (en)
Inventor
Park Yoon-Jeong
Chung Chong-Pyoung
Lee Seung-Jin
Lee Jue-Yeon
Original Assignee
Seoul National Univ Industry Foundation
Seoul Nat Univ R&Db Foundation
Nibec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul National Univ Industry Foundation, Seoul Nat Univ R&Db Foundation, Nibec Co Ltd filed Critical Seoul National Univ Industry Foundation
Publication of BRPI0706921A2 publication Critical patent/BRPI0706921A2/pt
Publication of BRPI0706921A8 publication Critical patent/BRPI0706921A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Ceramic Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

MATERIAL PAPA ENXERTO ÓSSEO, ARCABOUÇO PARA APLICAÇÕES DE ENGENHARIA DE TECIDO, COMPOSIÇÃO FARMACÊUTICA PARA A RECUPERAÇÃO DA REGENERAÇÃO DE TECIDOS A presente invenção refere-se a uma composição farmacêutica compreendendo um material para enxerto ósseo, um arcabouço para aplicações de engenharia de tecidos que têm um peptídeo promotor de calcificação óssea imobilizado na superfície e, mais particularmente, a um material para enxerto ósseo e um arcabouço para aplicações de engenharia de tecidos doravante, denominado arcabouço), que têm peptídeos imobilizados na superfície que induzem especificamente a ligação do colágeno tipo I, e uma composição farmacêutica para a recuperação da regeneração de tecidos contendo um peptídeo indutor de ligação de colágeno tipo I. Este peptídeo induz a ligação de colágeno tipo I (principal ingrediente da matriz extracelular) no material inventivo para enxerto ósseo e no arcabouço para aplicações de engenharia de tecidos, o que aumenta a taxa de diferenciação das células relacionadas à regeneração aderidas à superfície e, portanto, promovem sua calcificação, último passo da regeneração óssea e que finalmente maximiza a regeneração dos tecidos.
BRPI0706921A 2006-02-03 2007-01-19 Material para enxerto ósseo, arcabouço para aplicações de engenharia de tecido, composição farmacêutica para a recuperação da regeneração de tecidos BRPI0706921A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020060010712A KR100739528B1 (ko) 2006-02-03 2006-02-03 제1형 교원질 부착 유도 펩타이드가 고정된 골이식재 및 조직공학용 지지체
KR10-2006-0010712 2006-02-03
PCT/KR2007/000335 WO2007089084A1 (en) 2006-02-03 2007-01-19 Bone graft and scaffolding materials immobilized with type i collagen binding peptides

Publications (2)

Publication Number Publication Date
BRPI0706921A2 BRPI0706921A2 (pt) 2011-04-12
BRPI0706921A8 true BRPI0706921A8 (pt) 2015-10-06

Family

ID=38327619

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0706921A BRPI0706921A8 (pt) 2006-02-03 2007-01-19 Material para enxerto ósseo, arcabouço para aplicações de engenharia de tecido, composição farmacêutica para a recuperação da regeneração de tecidos

Country Status (6)

Country Link
US (1) US8349804B2 (pt)
EP (1) EP1981556B1 (pt)
JP (1) JP5298283B2 (pt)
KR (1) KR100739528B1 (pt)
BR (1) BRPI0706921A8 (pt)
WO (1) WO2007089084A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10300167B2 (en) * 2006-03-24 2019-05-28 Cabertech, Inc. Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture
US20100023129A1 (en) * 2008-07-22 2010-01-28 Guo-Feng Xu Jawbone prosthesis and method of manufacture
CN101332314B (zh) * 2008-07-22 2012-11-14 广东冠昊生物科技股份有限公司 生物型关节软骨修补件
KR100894265B1 (ko) * 2007-06-05 2009-04-21 재단법인서울대학교산학협력재단 골형성 촉진 펩타이드를 함유하는 주입형 골재생재
GB0808350D0 (en) * 2008-05-09 2008-06-18 Airbus Uk Ltd Self-cleaning surfaces
WO2010001149A2 (en) * 2008-07-04 2010-01-07 Fujifilm Manufacturing Europe Bv Coating method for medical devices
US20110117168A1 (en) 2009-11-18 2011-05-19 Affinergy, Inc. Methods and compositions for soft tissue repair
KR101400667B1 (ko) * 2011-04-22 2014-05-30 주식회사 나이벡 펩타이드에 의한 표면활성형 콜라겐 차폐막
KR101400668B1 (ko) * 2011-04-22 2014-05-30 주식회사 나이벡 펩타이드에 의한 표면활성형 콜라겐 차폐막
US9157908B2 (en) 2011-04-22 2015-10-13 University Of Washington Through Its Center For Commercialization Chitosan-alginate scaffold cell culture system and related methods
US9404097B2 (en) 2011-09-30 2016-08-02 Korea University Research And Business Foundation Peptide capable of silica deposition and use thereof
KR101628677B1 (ko) * 2013-04-02 2016-06-09 주식회사 나이벡 세포외기질 단백질-골미네랄 복합체를 함유하는 조직 구조 모사체 및 그 제조방법
KR101638775B1 (ko) * 2014-07-24 2016-07-13 서울대학교산학협력단 신규한 지방 축적 억제용 펩타이드 및 이를 포함하는 비만 예방 또는 치료용 약학조성물
KR102123539B1 (ko) * 2018-01-25 2020-06-16 중앙대학교 산학협력단 골 형성 촉진용 조성물
CN110464873B (zh) 2019-06-06 2020-05-05 重庆大学 具有消除表面生物膜功能的医用钛植入体的制备方法
CN115970067B (zh) * 2023-01-17 2023-10-17 中山大学附属口腔医院 一种智能化引导骨组织再生膜及其制备方法和应用
CN116570753B (zh) * 2023-07-13 2023-09-22 健诺维(成都)生物科技有限公司 一种组织再生型生物膜组织复合物及制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960005871B1 (ko) * 1986-05-15 1996-05-03 스미또모 시멘트 가부시끼가이샤 인공생체복합재료
US5574134A (en) * 1989-07-11 1996-11-12 University Of Delaware Polypeptide monomers, linearly extended and/or crosslinked forms thereof, and applications thereof
US5635482A (en) * 1989-08-14 1997-06-03 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US5853744A (en) * 1996-08-20 1998-12-29 Regents Of The University Of Minnesota Solid-phase method for attaching a biomolecule to a substrate surface with a photoreactive crosslinking agent
EP1003570A1 (en) * 1997-08-15 2000-05-31 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
EP1100558A1 (en) * 1998-07-24 2001-05-23 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US20020102709A1 (en) * 1999-02-19 2002-08-01 Tetsuya Ishikawa Collagen-binding physiologically active polypeptide
US6696073B2 (en) * 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
CA2370301A1 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor
US6949251B2 (en) * 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
KR100427557B1 (ko) 2001-03-26 2004-04-27 주식회사 웰스킨 뼈의 콜라겐 지지체
GB0309064D0 (en) * 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
AU2004305574B2 (en) * 2003-12-10 2010-08-26 Cellular Bioengineering, Inc. Methods and composition for soft tissue feature reconstruction
US20090005298A1 (en) * 2004-02-27 2009-01-01 The University Of Western Ontario Bone Sialoprotein Collagen-Binding Peptides
KR101013999B1 (ko) * 2004-03-19 2011-02-14 재단법인서울대학교산학협력재단 표면에 골조직 형성 증진 펩타이드가 고정된 차폐막 및임플란트
KR100676945B1 (ko) * 2005-03-18 2007-02-01 재단법인서울대학교산학협력재단 표면에 골조직 형성 증진 펩타이드가 고정된 골이식재 및 조직공학용 지지체

Also Published As

Publication number Publication date
BRPI0706921A2 (pt) 2011-04-12
JP5298283B2 (ja) 2013-09-25
EP1981556A4 (en) 2012-08-15
WO2007089084A1 (en) 2007-08-09
JP2009527263A (ja) 2009-07-30
EP1981556B1 (en) 2014-01-01
EP1981556A1 (en) 2008-10-22
KR100739528B1 (ko) 2007-07-13
US20110045048A1 (en) 2011-02-24
US8349804B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
BRPI0706921A8 (pt) Material para enxerto ósseo, arcabouço para aplicações de engenharia de tecido, composição farmacêutica para a recuperação da regeneração de tecidos
DE502007006879D1 (de) Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial
CL2008000316A1 (es) Compuestos derivados de 2-metilsulfonil-1,2,3,4-tetrahidroisoquinolina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la diabetes, hiperlipidemia, enfermedades cardiacas, artritis, osteoporosis, hipertension, catara
CL2014000550A1 (es) Metodo para modular funcion y/o la expresion de uno o más de polinucleótido o proteína de subunidad alfa de canal de sodio regulado por voltaje en sistemas biológicos; composición farmacéutica que comprende uno o mas compuestos que modulan la expresion de uno o mas polinucleotidos de subunidad alfa de canal de sodio regulado por voltaje.
CO6270235A2 (es) Un peptido de proiselt seleccionado de un grupo acetilo n-terminal, amida y cisteine
DK1530446T3 (da) Implantat til implantation i knoglevæv eller i knoglevæv suppleret med knogleerstatningsmateriale
BRPI0911681A2 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula
CL2012001722A1 (es) Compuestos derivados de 3-hidroxi-5-arilisotiazol, agonistas del receptor 40 acoplado a la proteina g (gpr40); composición farmacéutica que los comprende; y método para el tratamiento o la prevención de la diabetes.
PT2029480T (pt) Nanopartículas biologicamente ativas de uma hidroxiapatite substituída por carbonato, processo para a sua preparação e composições que as incorporam
EP2446862A3 (en) Amphiphilic peptides and hydrogel matrices thereof for bone repair
EP2664341A3 (en) Native (telopeptide) placental collagen compositions
BRPI0713153B8 (pt) tetrapeptídeo capaz de induzir a produção das proteínas da matriz extracelular e composição o compreendendo
BRPI0919414A2 (pt) Inibição da interação entre hif-1alfa e p300/cbp com hélices à base de substituintes de ligação de hidrogênio
BRPI0821165B8 (pt) uso de uma composição
BRPI0718615B8 (pt) processo para produzir um material elástico a partir de tropoelastina e material elástico
BR112017021970A2 (pt) bioconjugados e usos dos mesmos
MX2009011181A (es) Uso nuevo del hidroxitirosol.
BRPI0916188A2 (pt) Série de composto para clareamento da pele (iluminação)
BRPI0720879B8 (pt) microvesícula derivada de levedura carreadora de fator tissular (tf), composição e composição farmacêutica que a compreende e processos para a sua fabricação
CL2007001886A1 (es) Compuestos derivados de ureas de piperidina o pirrolidina; procedimiento de preparación; composición farmacéutica; y su uso como moduladores de la actividad de la 11ß-hidroxiesteroide deshidrogenasa tipo 1 (11ßhsd1) para tratar la obesidad, diabetes, resistenacia a la insulina, síndrome de cushing e hipertensión, entre otros.
WO2009072119A3 (en) Amphiphilic peptide matrices for treatment of osteoporosis
NI200700075A (es) Acidos 4-((fenoxialquil)tio)-fenoxiaceticos y analogos
BR112017028581A2 (pt) implante ortopédico
DK2308027T3 (da) Scoringssystem til monitorering af naturlig eller lægemiddelmodificeret sygdomsprogression i erosiv osteoarthritis i fingres interphalangealled
BRPI0617493B8 (pt) hidroxiapatita multisubstituída e seu compósito com um polímero natural e/ou sintético, preparo e usos dos mesmos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: SEOUL NATIONAL UNIVERSITY RANDDB FOUNDATION (KR) ,

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]